Clínic Barcelona

New CAR-NK cell immunotherapy is tested in refractory invasive fungal infection

A multidisciplinary team of researchers from the Hospital Clínic Barcelona-IDIBAPS-UB, coordinated by Carolina García-Vidal and Pedro Puerta of the Hospital Clínic Infectious Diseases Service, has launched a clinical trial to evaluate the safety and efficacy of a new adoptive cellular immunotherapy in patients with fungal infections resistant to conventional treatment.

From left to right, María Velasco, Carolina García-Vidal, Álex Soriano, Pedro Puerta and Francisco Lozano.

Keep reading about: